JVIR INSTRUCTIONS FOR AUTHORS
Updated September 2011
All manuscripts must be submitted online at 
http://ees.elsevier.com/jvir.
Questions related to the status of manuscripts should be addressed to:
Noemi C. Arthur
Senior Director of Communications,
Publications & Clinical Practice
Society of Interventional Radiology
3975 Fair Ridge Drive, Suite 400 North
Fairfax,
VA 22033
Telephone: 703.460.5593
Fax: 703.691.1855
E-mail: JVIR@SIRweb.org
The Journal of Vascular
and Interventional Radiology (JVIR) is devoted to the timely publication of peer-reviewed clinical and laboratory studies in the
field of vascular and interventional radiology. JVIR is the official journal of the Society of Interventional Radiology (SIR).
Statements made in published articles are the responsibility of the authors and not that of JVIR or SIR.
These instructions
follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (N Engl J Med 1997; 336:309 or see http://www.icmje.org/index.html).
Once accepted, manuscripts are copy edited to conform to JVIR's standards and style. Accepted manuscripts become the property
of JVIR and may not be published in whole or in part without the express written permission of the author(s) and JVIR (see
section below, Rights and Permissions).
Transfer of Copyright and Exclusive Submission Agreements
As part of the submission
process, authors will be required to complete an electronic copyright transfer form, certificate of exclusive submission, and financial
disclosure statement. For officers or employees of the U.S. government, JVIR recognizes that works prepared as part of their official
government duties are in the public domain, but they must still complete the relevant forms. Authors will also be required to disclose
whether submissions involve authors with financial interests in a company or organization and a notation of the financial relationship
will be included as a footnote on the first page of the article.
Manuscripts will only be reviewed and accepted with the understanding
that they are contributed solely to JVIR. Authors must be certain that no manuscript on the same or similar material has been,
or will be, submitted to another journal by themselves, their co-authors, or others at their institution prior to their work appearing
in JVIR. The submission by authors of similar material to advertising, broadcast, or electronic media must be indicated at the
time manuscripts are received by JVIR.
Requests to reproduce material from JVIR should be made to:
Permissions
Global Rights Department
Elsevier Inc.
Oxford, UK
Phone: +1 215-239-3804 or +44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: healthpermissions@elsevier.com
Journal authors retain rights for a large number of author uses, including
use by your employing institution or company. These rights are retained and permitted without the need to obtain specific permission
from Elsevier. For information about what author-uses are retained by the journal author, please visit http://www.elsevier.com/wps/find/authorsview.authors/authorsrights.
Ethical Conduct of Studies
It is the author's responsibility to ensure that patient anonymity is carefully protected.
Authors from U.S. institutions must comply with all regulations of the Health Insurance Portability and Accountability Act (HIPAA) of
1996.
If an Institutional Review Board (IRB) exists at the institution(s) in which any study involving human subjects is conducted,
the investigators must obtain prior IRB approval. This requirement applies to prospective and retrospective studies (including technical
notes and case reports) that involve any direct interaction with patients OR evaluation or review of private information (eg, imaging
studies or chart reviews). See Valji K. IRB Approval--Who Needs It? J Vasc Interv Radiol 2002; 13:225-226.
If the IRB at the participating
institution does not require approval for the type of research being performed, a statement to this effect must be included in the manuscript.
If no IRB existed at the time the study was initiated, the authors must include a statement in the manuscript to this effect, as well
as a second statement that the principles of the Declaration of Helsinki ( http://www.nihtraining.com/ohsrsite/guidelines/helsinki.html)
were followed. If a manuscript reports on the emergent use of a material or device not approved by the Food and Drug Administration or
accepted as standard practice, the authors must state that they obtained informed consent from the patient (when feasible) and reported
the case to the local IRB within 1 week of the event. This procedure is only valid for a single patient.
Manuscripts reporting research
involving animals must include a statement that either the protocol was approved by an institutional animal care board or that the animal
care complied with the "Principles of Laboratory Care" (formulated by the National Society for Medical Research) or the "Guide for the
Care and Use of Laboratory Animals" (National Institutes of Health).
Authorship
Any person listed as a manuscript author
should have made substantive intellectual contributions to the study as established by the International Committee of Medical Journal
Editors (ICMJE, www.icmje.org). All authors should meet each of the following
conditions with regard to the manuscript: (1) Substantial contributions to conception and design, or acquisition of data, or analysis
and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval
of the version to be published.
Reporting Standards
In order to ensure consistency in reporting the results of clinical
research, the Society of Interventional Radiology has developed a number of reporting standards documents that authors should follow
when submitting manuscripts for consideration. Adherence to relevant reporting standards will be taken into account in the review process.
Links to these documents are given below. Alternatively, go to the www.JVIR.org
home page and select Reporting Standards on the left-hand menu bar.
1. Sacks, D., McClenny, T.E., Cardella, J.F., et al. Society
of Interventional Radiology Clinical Practice Guidelines. J Vasc Interv Radiol 2003; 14:199S-202.
2. Sacks, D., Marinelli, D.L.,
Martin, L.G., et al. General Principles for Evaluation of New Interventional Technologies and Devices. J Vasc Interv Radiol 2003;
14:391S-394.
3. Rundback, J.H., Sacks, D., Kent, K. C., et al. Guidelines for the Reporting of Renal Artery Revascularization
in Clinical Trials. J Vasc Interv Radiol 2003; 14:477S-492.
4. Recommended Reporting Standards for Vena Caval Filter Placement
and Patient Follow-Up. J Vasc Interv Radiol 2003; 14:427S-432.
5. Millward, S.F., Grassi, C.J., Kinney, T.B., et al., for the
Technology Assessment Committee of the Society of Interventional Radiology, Reporting Standards for Inferior Vena Caval Filter Placement
and Patient Follow-up: Supplement for Temporary and Retrievable/Optional Filters. J Vasc Interv Radiol 2005; 16:441-443.
6. Higashida,
R.T., Meyers, P.M., Phatouros, C.C., et al. Reporting Standards for Carotid Artery Angioplasty and Stent Placement. J Vasc Interv
Radiol 2004; 15:e1-24.
7. Sacks, D., Marinelli, D.L., Martin, L.G., et al. Reporting Standards for Clinical Evaluation of New
Peripheral Arterial Revascularization Devices. J Vasc Interv Radiol 2003; 14:395S-404.
8. Haskal, Z.J., Rees, C.R., Ring, E.J.,
Saxon, et al. Reporting Standards for Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol 2003; 14:419S-426.
9. Gray, R.J., Sacks, D., Martin, L.G., et al. Reporting Standards for Percutaneous Interventions in Dialysis Access. J Vasc
Interv Radiol 2003; 14:433S-442. 10. Silberzweig, J.E., Sacks, D., Khorsandi, A.S., et al. Reporting Standards for Central Venous Access.
J Vasc Interv Radiol 2003; 14:443S-452.
11. Goodwin, S.C., Bonilla, S.C., Sacks, D., et al. Reporting Standards for Uterine Artery
Embolization for the Treatment of Uterine Leiomyomata. J Vasc Interv Radiol 2003; 14:467S-476.
12. Patel, N., Sacks, D., Patel,
R.I., et al. SIR Reporting Standards for the Treatment of Acute Limb Ischemia with Use of Transluminal Removal of Arterial Thrombus.
J Vasc Interv Radiol 2003; 14:453S-465.
13. Trial Design and Reporting Standards for Intraarterial Cerebral Thrombolysis for Acute
Ischemic Stroke. J Vasc Interv Radiol 2003; 14:493S-494.
14. Veith, F.J., Abbott, W.M., Yao, J.S.T., et al. Guidelines for
Development and Use of Transluminally Placed Endovascular Prosthetic Grafts in the Arterial System. J Vasc Interv Radiol 2003; 14:405S-417.
15. Goldberg, S. N., Grassi, C.J., Cardella, J.F., et al. Image-guided Tumor Ablation: Standardization of Terminology and Reporting
Criteria. J Vasc Interv Radiol 2005; 16:765-778.
16. Vedantham, S., Grassi, C.J., Ferral, H., et al. Reporting Standards for
Endovascular Treatment of Lower Extremity Deep Vein Thrombosis. J Vasc Interv Radiol 2006; 17:417-434.
17. Kundu A, Lurie F,
Millward S, et al. Recommended Reporting Standards for Endovenous Ablation for the Treatment of Venous Insufficiency: Joint Statement
of the American Venous Forum and the Society of Interventional Radiology. J Vasc Interv Radiol 2007; 18:1073-1080.
18. Brown,
Daniel B., Gould, Jennifer E., Gervais, Debra A., et al. Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology
and Reporting Criteria. J Vasc Interv Radiol 2007; 18:1469-1478.
19. Clark, TWI, Millward, SF, Gervais, DA, et al. Reporting Standards
for Percutaneous Thermal Ablation of Renal Cell Carcinoma. J Vasc Interv Radiol 2009; 20:S409-S416.
20. Meyers, PM., Shumacher,
HC, Higashida, RT, et al. Reporting Standards for Endovascular Repair of Saccular Intracranial Cerebral Aneurysms. J Vasc Interv
Radiol 2009; 20:S435-S450.
21.Schumacher, HC, Meyers, PM, Higashida, RT, et al. Reporting Standards for Angioplasty and Stent-assisted
Angioplasty for Intracranial Atherosclerosis. J Vasc Interv Radiol 2009; 20:S451-S473.
22. Rose, SC, Dupuy, DE, Gervais, DA,
et al. Research Reporting Standards for Percutaneous Thermal Ablation of Lung Neoplasms. J Vasc Interv Radiol 2009; 20:S474-S485.
CONSORT Criteria
Beginning October 1, 2009, authors will be asked to upload the CONSORT criteria and checklist when
submitting a manuscript. JVIR formally endorses the CONSORT (Consolidated Standards of Reporting Trials) Statement. The CONSORT
Statement contains criteria developed to improve the quality of published reports of randomized clinical trials. The current criteria
consist of a 22-item checklist that pertains to the various sections of a report of a clinical trial (Title, Abstract, Introduction,
Materials and Methods, Results, and Discussion). The CONSORT criteria have been adopted by many leading medical journals as a template
for reporting randomized clinical trials. JVIR encourages clinical investigators to familiarize themselves with the criteria,
voluntarily follow these guidelines when reporting randomized clinical trials, and follow them as closely as possible for non-randomized
trials. Beginning October 1st, when submitting a manuscript reporting a randomized controlled trial, authors are strongly encouraged
to upload the CONSORT criteria checklist and flow diagram and to attach the completed checklist to their submission. Initially these
elements will not be mandatory. Although the criteria apply strictly to randomized controlled trials, authors of other types of submissions
may find the criteria helpful in the development of a strong manuscript. For more information on the CONSORT Statement, please visit
http://www.consort-statement.org/home/. In addition to viewing the checklist and flow diagram, please also read the CONSORT
Explanation and Elaboration document found on the Web site, which explains and illustrates the principles underlying the CONSORT Statement.
When referring to the CONSORT Statement, please use any of the following journal article citations rather than referring to the CONSORT
Statement Web site.
-
- Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357(9263):1191-1194.
- Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285(15):1987-1991.
- Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134(8):657-662.
Also, since the CONSORT Statement should be read in conjunction with the CONSORT Explanation and Elaboration Document, you should also cite:
Altman DG, Schulz KF, Moher D, Egger M. Davidoff F, Elbourne D, Getzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134(8):663-694.
Note to Authors from Non-English Speaking Countries
JVIR publishes manuscripts only in English. This includes using the American variant of spelling and decimal points. To assist you in preparing your manuscript in its best possible form, we recommend you take advantage of online resources provided by our publisher, Elsevier, Inc. Please visit "Language Editing" online at www.elsevier.com/wps/find/authorsview.authors/languagepolishing. Alternatively, you may contact the American Medical Writers Association (www.amwa.org); the Council of Science Editors (www.councilscienceeditors.org; click on Job Bank, then Manuscript Services), or the Society for Scholarly Publishing (www.sspnet.org; click on Services Directory and choose the category, Copy Editing).
Types of Manuscripts
JVIR publishes several types of articles, each of which has a distinct format:
- Clinical Studies and Laboratory Investigations are the central focus of the Journal and are based on original clinical or experimental studies. The complete format is described under the Manuscript Preparation section.
- Brief Reports include descriptions of a new or modified interventional procedure or device and small clinical studies or case reports. A brief, one-paragraph abstract (fewer than 100 words) should be included. In general, limit the paper to six pages of text, 15 references, and no more than eight figure parts.
- Letters to the Editor can be used to offer commentary on any material published in JVIR, such as new or modified techniques and individual studies or cases. Letters may also be used to convey material of more general interest to the interventional radiology community. On occasion, the Editor may offer such space for submitted case reports that do not receive high enough priority for publication as such. Letters should be no longer than three pages with no more than four references. Only one figure (with no more than four figure parts) can be submitted. Letters to the Editor are accepted for publication at the discretion of the Editor and may be copyedited for content and length. Letters that relate to a published article will be published pending response from the original article's author.
- Book Reviews are submitted through the office of the Book Review Editor. Please contact Diane Washington at the office of Dr. Alan H. Matsumoto, MD, FSIR (ddw3u@virginia.edu)
- Review Articles are generally invited by the Editor. Specific instructions are provided at the time of invitation. The Editor will accept unsolicited review articles.
- Images in IR consist of 1 to 4 images demonstrating a unique anatomic finding, an unusual diagnosis, or an innovative intervention that exemplifies interventional radiologic therapies. The manuscript should include a title that will fit on one line of printed text (45 to 50 characters-not words-including spaces). The accompanying explanatory text, which should not exceed 150 words, should include the description of the figures, relevant findings, background, and clinical information. Separate figure legends and references should not be submitted. For technical submission requirements, see under "Figures" below.
Manuscript Preparation
The preferred word processing program is Microsoft Word. Manuscripts must be written with 12 point font, double-spaced throughout (including tables, references, and figure legends), and have at least 3-cm margins. The text should be ragged right (no right justification). Embedded instructions (eg, italics, underlines, boldface) should not be used or should be kept to a minimum. Do not use coding for centering. Insert only one space after punctuation marks. Sequential page numbering should begin with the text. The order of sections is Abstract, Text, References, Tables, and Figure Legends. To ensure blinded peer-review, no direct references to the author(s) or institution(s) of origin should be made anywhere in the text or figures.
Title Page
Include a title page as a separate document. List all author affiliations, any conflicts of interest and financial disclosures, and whether the material was presented at an SIR Annual Meeting. Also, please list any acknowledgments.
- • Acknowledgments: On the title page, list any significant contributors to the conduct of the study or preparation of the manuscript other than your co-authors. Authors are responsible for obtaining permission from persons acknowledged for support that is other than technical, secretarial, or financial
Text
- Abstract: The abstract for original clinical and laboratory investigations should be no longer than 250 words and should include Purpose, Materials and Methods, Results, and Conclusion. For brief reports and review articles, the abstract is a short (fewer than 100 words) unstructured paragraph. Remember that many readers will only come to know the authors' work through the abstract. Actual data (with statistical significance) should be included in the Results. The conclusions should be drawn directly from the results of the study. Note that the conclusion will be used as a summary statement of your work in the printed Table of Contents.
- Introduction: Provide a brief summary (usually less than one page) of background material to set the stage for your paper. This section should end with a succinct statement of the purpose of your study.
- Materials and Methods: Describe the nature of the subjects, methods of selection, materials (including manufacturers' names and locations - city and state or country), and all procedures. The characteristics of study group(s) (such as sex distribution, mean age, underlying medical problems) should be included in this section. References should be made to established methods that have been published. New or substantially modified methods should be described, supported with rationale, and critically evaluated for real and potential limitations. This section should conclude with a description (and references and names of computer software packages, when appropriate) of all statistical methods used to analyze the data.
- Results: Report of data and observations should be in logical sequence in the text, tables and illustrations. Data given in tables should not be repeated in the text. Complex reports may require subheadings in this section.
- Discussion: Consider new and important aspects of the study and conclusions that can be drawn directly from your data. Include implications of findings, and relate observations to other relevant studies. Include a separate paragraph that outlines the limitations of your study. Avoid claiming priority, alluding to work that has not been completed, or making unqualified statements not supported by your data. Recommendations, when appropriate, should be made.
- References: Number the references in the order in which they appear in the text (including references in tables at the site where they are mentioned in the text). Reference numbers appear on line within parentheses (not bracketed, not superscripted). With the exception of review articles, no more than 35 to 40 references should be made. The abbreviations used for periodicals follow the style of Index Medicus. Unpublished data are not cited in the reference list but cited parenthetically in the text. For individuals using computer bibliographies (eg, End Note), JVIR style is modified Vancouver (exceptions to Vancouver include: give the names of all authors up to six; if there are more than six authors, use the first three names followed by et al.; use minimal punctuation, with no periods for author initials; do not include issue numbers; use complete page ranges). The use of references for which no English translation or abstract is available is acceptable only if this is the sole source of primary information relevant to the submitted manuscript. However, given the difficulty such references pose to reviewers and readers, authors are asked to limit their use to the extent possible.
o For journal articles with six or fewer authors, list surnames and initials of all authors, such as:
- Gupta S, Madoff DC. Image-guided percutaneous needle biopsy in cancer diagnosis and staging. Tech Vasc Interv Radiol 2007; 10:88-101.
- Larson AC, Wang D, Atassi B, et al. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma-feasibility of initial translation. Radiol 2008; 234:964-971.
- Nemcek AA, Resnick S. Case 2: Swollen leg. In: Brown DB, ed. 2008 Case-Based Review Monograph. Fairfax: Society of Interventional Radiology, 2008; 7-12.
- Oppenheimer JD, Ryu RK, Kasuganti D, et al. Surgically proven malignancy in thyroid US-guided FNA biopsies interpreted as nondiagnostic, malignant, and benign. Presented at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology; March 19, 2008; Washington, DC.
- Raymond EB, Grassi, CJ, Edward IB, et al. Practice guideline for the performance
of physiologic evaluation of extremity arteries. J Vasc Interv Radiol 2007; 18:1203-1206. Available at http://www.sirweb.org/clinical/outside.shtml
. Accessed April 21, 2008.
Units of Measure and Abbreviations
Laboratory values and radiation measurements should be given in the International System of Units (SI). Standard base and derived SI units are listed on the site of the International Bureau of Weights and Measures at
http://www.bipm.org/en/si/
or at http://www.unc.edu/~rowlett/units/sipm.html. Additional information on standards, references, and guides published
by various standards organizations is available on the US Metric Association site at http://lamar.colostate.edu/~hillger/si-publications.html All abbreviations should be defined at first mention in the manuscript, with the abbreviation following in parentheses. Use the abbreviation thereafter. Laboratory slang and clinical jargon should be avoided, and unconventional abbreviations should be kept to a minimum. Please note that some of the Reporting Standards documents address the use of specific abbreviations and acronyms in scientific manuscripts.
Tables
- Please do not embed tables in the body of the manuscript. Submit them in separate files, one file for each table, and include your name and the table number in the file name.
- Construct tables using the table creating and editing feature of your word processing program Do not use tabs to create columns. Do not use Excel or comparable spreadsheets.
- Do not include vertical lines or shading in the tables, and avoid excessive use of horizontal lines.
- Make sure that all tables are referenced in the text and numbered sequentially using Arabic numerals. If, during the revision process, you need to drop / add / move a table to a different location, please make the necessary adjustments to the table numbers, corresponding text citations, and table file names.
- Important! To avoid unnecessary delays, please remove from the EES manuscript submission system any tables previously submitted but not included in the final, accepted manuscript. The same tables should appear in the manuscript and in the EES database
- Make sure that your tables summarize or supplement rather than repeat information provided in the text.
- Make sure that each table has a title that briefly identifies the table's content briefly. Please avoid verbs and relative clauses in the table title-the title should be substantival in form.
- Please avoid mixing different kinds of information (eg, numbers with percentages) in columns. Each column should be assigned to a specific type of information, and column heads should be grammatically consistent.
- Please ensure the logical and grammatical consistency of the items listed in each column. If an item appears several times, make sure that it is listed under the same name and form throughout.
- For quantitative data, double-check column totals to ensure accuracy.
- Expand all abbreviations in a table footnote.
- Double-check for consistency any letter / number combinations, including hyphens and superscripts (eg, not Gy-cm2 in one place and Gy cm2 in another).
- Make sure that any symbols used in the table for footnotable material match the symbols used in the footnotes. For instance, do not use letters in the table body but single, double, or triple astericks in the footnotes. To simplify the copyediting process, we recommend using the following symbols in this order: *,†, ‡, §, || When more symbols are needed, double or triple the basic symbols (**, ††, ‡‡, §§).
- If a table has been published previously, please provide full credit to the original source in the table footnote. See also the Rights and Permissions section below.
Figures
Technical Submission Requirements
Please use graphics software such as Photoshop and Illustrator to create art. Submit figures electronically in individual files saved in EPS or TIF file formats. Figures submitted in presentation software such as PowerPoint, CorelDraw, or Harvard Graphics are not acceptable. Please save color images as CMYK in at least 300 dots per inch (dpi), and grayscale images in at least 300 dpi. Please note that color images are published at the discretion of the editorial office. In the online version of the Journal, the figures will be reproduced in color. Line art (black and white or color) and combinations of grayscale and line art should be at least 300 dpi. Please make sure to create your original art at the proper resolution. Once you create digital art at low resolution, you cannot adjust it later. For step-by-step instructions and screenshots on how to create your art correctly the first time, go to www.elsevier.com/artworkinstructions.
Your figures may move into review even if they do not meet production standards; however, you should be prepared to provide better quality figures should JVIR express interest in your manuscript.
- Important! To avoid unnecessary delays, please remove from the EES manuscript submission system any figures previously submitted but not included in the final, accepted manuscript. The same figures should appear in the manuscript and in the EES database.
Summary of Technical Requirements for Halftones: Radiographs, Photographs, or Scanned Images
Basic parameters
- File Type: TIF
Resolution: 300 dpi
Color mode: grayscale or CMYK
Greatest dimension (inches): 7"
Greatest dimension (pixels): 2100
- Grayscale: 1-4 MB
CMYK: 4-16 MB
Basic parameters
- File Type: TIFF or EPS
Resolution: 1200 dpi
Color mode: Bitmap, grayscale or CMYK
Greatest dimension (inches): 7"
Greatest dimension (pixels): 8400
- Grayscale: 24 MB
Bitmap: 3 MB
http://www.elsevier.com/wps/find/authors.authors/authorartworkinstructions, where you can also find information on multimedia submission. For additional technical queries, contact Elsevier AuthorSupport@Elsevier.com
Editorial Requirements
DEFINITIONS
Figure This term covers both half tones and line art.
-
Halftones
- any digitally generated image characterized by gradations of shading, thus photographs, transparencies, but also any line-drawn illustration
that contains gradient tones from light to dark.
Line art - line-drawn illustrations (charts, diagrams, drawings) without any gradient tones.
Caption Statement / headline / that identifies the content of a figure in title form.
Legend Statement that describes / explains the contents of the figure in one or more sentences.
-
Some figures have
only captions, others have both captions and legends, while still others just legends. It is preferable for a figure to have both a caption
and a legend, but in some instances either one or the other are appropriate. The following example contains both a caption and a legend
consisting of four parts (a-d):
• Figure 2. Technical steps of urethral stent placement. (a) Initial right anterior oblique RUG via a catheter (arrow). Note also the urethra (arrowhead) filled with contrast medium. (b) Insertion of a guide wire (arrow) into the urethra and bladder. Note also the perforation of the bladder (arrowhead). (c) Insertion of a 4-F sheath (arrow) loaded with a urethral stent (arrowheads) into the urethra. (d) Right anterior oblique RUG immediately after stent placement shows patency and expansion of the stent (arrowheads).
Key Explanation of colors, symbols, shading characteristics, and so forth used for variables in a graphs, as in the example shown below.
- Please supply a caption and/or legend for each figure, and make sure they do not duplicate text material.
- Submit captions / legends on one or more separate pages at the end of the manuscript. Cite figures in the text and number them in order of first mention.
- Before submitting the final manuscript, please review the figure - caption / legend numbering to verify that the figure number matches the corresponding caption / legend and text citation.
- For figures with parts, provide a caption describing the whole figure, if possible, and then describing the parts. The caption should be substantival in form. If, during the revision process, some figure parts need to be replaced, double-check the following points when submitting the final version: (1) there is a legend for each part, (2) part legends match the corresponding figure parts, (3) part labels (a, b, c, etc.) are listed in alphabetical sequence, and (4) no labels are duplicated either in the figure or in the legend. Duplication or nonsequential listing of the labels in either figures or parts leads to confusion and unnecessary delays.
- Please explain any arrows /arrowheads, boxes, circles, or other markers used in charts or in photographs in the legend.
- In diagrams / flowcharts / decision trees, definitions of processes, events, steps etc., should be consistent both logically and grammatically. Please do not use verbs in some places and nouns in others.
- Expand all abbreviations used in the figure or caption / legend in a footnote.
- Make sure that any symbols, labels, and keys used in one figure are terminologically and graphically consistent throughout. If color is used and referenced in the text, please ensure that the key matches the chart element it designates.
- Variables in graphs should be clearly and consistently defined. Any variable that appears in two or more figures should be listed in the same throughout.
- If a figure has been published previously, the legend must give full credit to the original source. See also the Rights and Permissions section below.
Additional Information for Electronic Publication Only
Under exceptional or special circumstances, JVIR will allow publication of additional tables, figures, or text (eg, ., methodology, explanations of analysis, etc) in the electronic version of the published manuscript. This material will not be included in the print version but a reference to its availability online will be present in the print version. The Editor would like to emphasize that such additional material will have to meet strict criteria to be included in the electronic version; such material may be used to complement the data in the printed version. If deemed by the authors or Editor as crucial to the interpretation of the manuscript, this material should be included as part of the printed version of the manuscript. Please mark clearly in the submitted manuscript that this is additional information to be published electronically. The electronic version should not be used as a repository for redundant or unnecessary data.
Video clips for electronic version: We will accept relevant video clips with accepted manuscripts for viewing in our online version of JVIR
Authors who are unable to provide an electronic version of their manuscript or have other circumstances that prevent online submission must contact the Journal staff prior to submission to discuss alternate options. The publisher and editor regret that they are not able to consider submissions that do not follow these procedures.
Manuscript Submission
All new manuscripts must be submitted through the JVIR online submission and review Web site at
http://ees.elsevier.com/jvir. Authors are requested to submit the text, tables,
and artwork in electronic form (not as a PDF) to this address. Authors will also be required to complete an electronic copyright transfer
form, certificate of exclusive submission, and financial disclosure statement. Authors are highly encouraged to suggest three or more
potential reviewers for their manuscript, with complete contact information.Submission items include:
-
- Cover letter (save as a separate file for upload)
- Title page
- Blinded manuscript (including abstract, main text, references, and table/figure legends),
- Tables
- Figures
- Revised manuscripts should also be accompanied by a unique file (separate from the cover letter) with responses to reviewers' comments as well as a copy of the manuscript with track changes/revisions visible.
- Cover letter
- Response to reviews (revised manuscripts only)
- Manuscript file(s)
- Table(s)
- Figure(s)
Authors can contact Elsevier with technical queries at: AuthorSupport@Elsevier.com.
Page Proofs and Corrections
Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages will be sent to the corresponding authors by e-mail, along with complete instructions for downloading. PDFs will also be annotatable, thus allowing authors to place comments directly on the PDF file before sending it to the Journal Manager via e-mail. The standard turnaround time is 48 hours from receipt. Please note that to access and work within the PDF, you will need to have Adobe Acrobat Reader software. If you are unable to add annotations to the PDF, please indicate what the corrections are via e-mail to Journal Manager Amy Messick at a.messick@elsevier.com, or mark the corrections and any other comments (including replies to queries) on a printout of the PDF file and fax to Amy's attention at 212.239.3388. Changes that have been made to conform to journal style will stand as long as they do not alter the author's meaning. Changes that are merely stylistic, consist of reworking of previously accepted material, or that are likely to modify the article layout will not be allowed. It is the author's responsibility to ensure that the proofs are free of errors.
Rights and Permissions
Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner and original author along with complete information as to the source. Photographs of identifiable persons must be accompanied by signed releases, showing informed consent. Articles appear in both the printed and online versions of JVIR and wording of the release should specify permission in all forms and media. Failure to obtain electronic permission rights may result in the images not appearing in the online version.
Publication of Supplements
Requests for publication in JVIR are reviewed by the Editor with advice from members of the JVIR Editorial Board. To be considered for publication, such supplements must have educational value and be useful to the general readership. The topic must be treated in an impartial, unbiased manner. JVIR will not consider publication of symposium proceedings for which JVIR has not participated in the planning process. The final decision to publish a symposium as a supplement to JVIR rests with the JVIR Editor and is based on the specific topic, the supplement editors, and the contributors.
Once a decision has been made to publish a symposium as a supplement to JVIR, the individual manuscripts undergo review. Individual authors are responsible for their own contributions, with overall quality the responsibility of the guest editor. All manuscripts are reviewed by the JVIR Editor, who retains complete and final editorial control of all supplement material, including the right to delete or add any additional material.